Why the study?
Does donor-recipient HLA matching improve survival, reduce rejection, or prevent death from coronary artery disease in cardiac transplant recipients?
Population
448 cyclosporine-treated heart transplant recipients
Comparison
Well-matched donor-recipient HLA vs Poorly matched donor-recipient HLA
Design
Cohort
Follow-up
up to 5 years
Authors
Loading...
Does not support HLA matching for survival benefit in heart transplant allocation; leaves open prospective trials on rejection reduction.
Does donor-recipient HLA matching improve survival, reduce rejection, or prevent death from coronary artery disease in cardiac transplant recipients?
Donor-recipient HLA matching in heart transplant recipients does not significantly improve survival but is associated with fewer rejection episodes.
Kerman et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: